According to the Zhitong Finance App, Times Angel (06699) announced interim results for the six months ended June 30, 2026, with revenue of US$231 million, up 42.98% year on year; profit attributable to shareholders of US$27.251 million, up 86.1% year on year; basic income per share of US$0.16. Adjusted net profit of US$35 million, an increase of 79.5% year over year. It is proposed to pay an interim dividend of HK$0.47 per share and a special dividend of HK$4.10 per share.
According to the announcement, in the first half of 2026, clinicians will pay more and more attention to products and services that are truly guided by clinical needs, driving the Group's business to achieve rapid growth. Overseas markets have performed particularly well. The total number of invisible correction cases and revenue have contributed more than half, and have achieved profits; mainland China's market share is also rising steadily. The Group's investment in professional education, direct sales networks and local service teams over the years has begun to produce scale effects; the corporate culture of open collaboration further promotes the deep integration of global clinical experience and continues to empower the Group to optimize treatment plans. The Group has gradually become a global enterprise in terms of talent, ability, culture and operation.
The Group's long-term commitment to global professional services infrastructure is also beginning to have a scale effect. Areas where the Group invests most include professional education, direct sales networks and local service teams, and these investments have also enhanced Angel's professional reputation and promoted steady improvement in profitability.